Literature DB >> 12706838

NF-kappaB and AP-1 regulate activation-dependent CD137 (4-1BB) expression in T cells.

Jae-Ouk Kim1, Ho Won Kim, Kyoung-Min Baek, Chang-Yuil Kang.   

Abstract

4-1BB(CD137) is a member of the tumor necrosis factor receptor superfamily and provides a costimulatory signal by interaction with 4-1BB ligand expressed on antigen-presenting cells. The expression of 4-1BB is known to be activation-dependent. Here, we investigated the transcriptional machinery required for T cell receptor (TCR) activation-dependent induction of 4-1BB expression in CD3-CEM cells treated with phorbol myristate acetate and ionomycin. Using 5'-deletion constructs of 4-1BB promoter in luciferase reporter assays, we demonstrated that the transcriptional elements mediating 4-1BB upregulation were located in the region between approximately 0.9 and approximately 1.1 kb from the translational start site. Characterization of these sites by electrophoretic mobility shift assay and site-directed mutagenesis revealed that nuclear factor kappaB (NF-kappaB) and activating protein-1 (AP-1) are involved. MEK and c-Jun N-terminal kinase-1 activity was required for activation-dependent 4-1BB upregulation. Thus, NF-kappaB and AP-1 are involved in the TCR stimulation-dependent transcriptional regulation of the 4-1BB promoter.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706838     DOI: 10.1016/s0014-5793(03)00326-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

1.  Regulation of mouse 4-1BB expression: multiple promoter usages and a splice variant.

Authors:  Jung D Kim; Chang H Kim; Byoung S Kwon
Journal:  Mol Cells       Date:  2011-01-11       Impact factor: 5.034

2.  TLR7 induces anergy in human CD4(+) T cells.

Authors:  Margarita Dominguez-Villar; Anne-Sophie Gautron; Marine de Marcken; Marla J Keller; David A Hafler
Journal:  Nat Immunol       Date:  2014-11-17       Impact factor: 25.606

3.  4-1BB Agonism Averts TIL Exhaustion and Licenses PD-1 Blockade in Glioblastoma and Other Intracranial Cancers.

Authors:  Karolina I Woroniecka; Kristen E Rhodin; Cosette Dechant; Xiuyu Cui; Pakawat Chongsathidkiet; Daniel Wilkinson; Jessica Waibl-Polania; Luis Sanchez-Perez; Peter E Fecci
Journal:  Clin Cancer Res       Date:  2019-12-23       Impact factor: 12.531

Review 4.  The pharmacology of second-generation chimeric antigen receptors.

Authors:  Sjoukje J C van der Stegen; Mohamad Hamieh; Michel Sadelain
Journal:  Nat Rev Drug Discov       Date:  2015-07       Impact factor: 84.694

Review 5.  Dual immunoregulatory pathways of 4-1BB signaling.

Authors:  Dass S Vinay; Kiweon Cha; Byoung S Kwon
Journal:  J Mol Med (Berl)       Date:  2006-08-05       Impact factor: 4.599

6.  Manipulating the tumor microenvironment ex vivo for enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy.

Authors:  Jessica Ann Chacon; Amod A Sarnaik; Jie Qing Chen; Caitlin Creasy; Charuta Kale; John Robinson; Jeffrey Weber; Patrick Hwu; Shari Pilon-Thomas; Laszlo Radvanyi
Journal:  Clin Cancer Res       Date:  2014-12-03       Impact factor: 12.531

7.  Transcriptional profiling of the LPS induced NF-kappaB response in macrophages.

Authors:  Omar Sharif; Viacheslav N Bolshakov; Stephanie Raines; Peter Newham; Neil D Perkins
Journal:  BMC Immunol       Date:  2007-01-12       Impact factor: 3.615

Review 8.  4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity.

Authors:  Todd Bartkowiak; Michael A Curran
Journal:  Front Oncol       Date:  2015-06-08       Impact factor: 6.244

9.  IκBα Nuclear Export Enables 4-1BB-Induced cRel Activation and IL-2 Production to Promote CD8 T Cell Immunity.

Authors:  Dominique N Lisiero; Zhang Cheng; Melba M Tejera; Brandon T Neldner; Jay W Warrick; Shelly M Wuerzberger-Davis; Alexander Hoffmann; M Suresh; Shigeki Miyamoto
Journal:  J Immunol       Date:  2020-08-14       Impact factor: 5.422

Review 10.  Dendritic cell apoptosis and the pathogenesis of dengue.

Authors:  Sharon de T Martins; Guilherme F Silveira; Lysangela R Alves; Claudia Nunes Duarte dos Santos; Juliano Bordignon
Journal:  Viruses       Date:  2012-11-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.